Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-19 to 2022-04-26
Current total value of award: $440471.79
Description: 8509037359!ADENOVIRUS TYPE 4 A